<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36180034</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Vaccine-associated paralytic poliomyelitis in a child: fast transformation from Sabin-like virus to vaccine-derived poliovirus triggered an epidemiological response in two countries of the European region.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>41</EndPage><MedlinePgn>35-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2022.09.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(22)00532-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The detection of a vaccine-derived poliovirus (VDPV) requires an epidemiological assessment and response. Using repeated stool sampling from a child who is immunocompetent and was vaccinated against poliomyelitis with acute flaccid paralysis, a case of an extremely rapid evolution of Sabin-like poliovirus (PV) type 3 was traced in the child's body.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The case was independently identified in two countries-Tajikistan and Russia. Stool samples for the study were also independently collected in two countries on different days from the onset of paralysis. Virological, serological, and molecular methods; full genome Sanger; and high-throughput sequencing were performed to characterize isolates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PV isolates from samples collected on days 2, 3, and 14 contained eight, seven, and seven mutations in the VP1-coding region, respectively, and were classified as Sabin-like PV type 3. The isolates from samples collected on days 15 and 18 had 11 mutations and were classified as vaccine-derived PVs, which required an epidemiological response in the two countries.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results indicate the need to continue acute flaccid paralysis surveillance, maintain high vaccination coverage, and develop and introduce new effective, genetically stable PV vaccines.</AbstractText><CopyrightInformation>Copyright Â© 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ivanova</LastName><ForeName>Olga E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia; Institute for Translation Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address: ivanova_oe@chumakovs.su.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlovskaya</LastName><ForeName>Liubov I</ForeName><Initials>LI</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia; Institute for Translation Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eremeeva</LastName><ForeName>Tatiana P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakaryan</LastName><ForeName>Armen K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia; Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanov</LastName><ForeName>Alexander P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baykova</LastName><ForeName>Olga Y</ForeName><Initials>OY</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasota</LastName><ForeName>Alexander Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia; Belozersky Institute of Physical-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shustova</LastName><ForeName>Elena Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafina</LastName><ForeName>Aida N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozova</LastName><ForeName>Nadezhda S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Federal Centre of Hygiene and Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobokhonova</LastName><ForeName>Makhtob S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>National Center for Immunoprophylaxis, Tajikistan Ministry of Health, Dushanbe, Tajikistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshevoi</LastName><ForeName>Sergei E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>World Health Organization office in the Russian Federation, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishmukhametov</LastName><ForeName>Aidar A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Chumakov Federal Scientific Centre for Research and Development of Immune-and-Biological Products of the Russian Academy of Science (Institute of poliomyelitis), Moscow, Russia; Institute for Translation Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013620" MajorTopicYN="N" Type="Geographic">Tajikistan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AFP</Keyword><Keyword MajorTopicYN="N">Epidemiological surveillance</Keyword><Keyword MajorTopicYN="N">Genome analysis</Keyword><Keyword MajorTopicYN="N">Immunization</Keyword><Keyword MajorTopicYN="N">VAPP</Keyword><Keyword MajorTopicYN="N">VDPV</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36180034</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.09.034</ArticleId><ArticleId IdType="pii">S1201-9712(22)00532-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle>